Healthcare DIVE March 7, 2024
Kristin Jensen

The administration wants to give Medicare the authority to subject 50 drugs to price negotiations each year.

Dive Brief:

  • President Biden is taking on a bipartisan bogeyman ahead of a critical State of the Union speech, targeting the pharmaceutical industry and saying he will work to expand the government’s power to lower drug prices.
  • In a fact sheet released Wednesday, the White House said Medicare should be allowed to negotiate prices for 50 medications every year. That would be a significant jump from the limit of 20 under the Inflation Reduction Act.
  • Biden is also looking to expand a $2,000 cap on out-of-pocket drug expenses to private insurers, extend a $2 cost-sharing limit for high-value generic drugs to all...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech
109 hospitals receiving new Medicare-backed residency slots
Senators urge Congress to avert Medicare physician pay cut
Podcast: Medicare Shared Savings Program Mints $2B Win for Value-Based Care w/ Frank McStay
Medicare Part D in 2025: A First Look at Prescription Drug Plan Availability, Premiums, and Cost Sharing
Dr. Oz, RFK Jr. on Medicare, Medicaid: 10 notes

Share This Article